Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants

article has not abstract

Vyšlo v časopise: Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants. PLoS Med 11(4): e32767. doi:10.1371/journal.pmed.1001636
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001636

Souhrn

article has not abstract

Zdroje

1. CooperER, CharuratM, MofensonL, HansonIC, PittJ, et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J AIDS 29: 484–494.

2. NesheimS, HarrisLF, LampeM (2013) Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges. Curr Opin HIVAIDS 8: 447–456.

3. The United States President's Emergency Plan for AIDS Relief. PEPFAR Tenth Annual Report To Congress (2014). See URL http://www.pepfar.gov/documents/organization/223065.pdf.

4. World Health Organization (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Available: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html

5. SibiudeJ, MandelbrotL, BlancheS, Le ChenadecJ, Boullag-BonnetN, et al. (2014) Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the ANRS CO1/CO11 French Perinatal Cohort Study. PLoS Med 11: e1001635.

6. TownsendCL, ByrneL, Cortina-BorjaM, ThorneC, de RuiterA, et al. (2014) Earlier initiation of ART and futher decline in mother-to-child HIV transmission rates, 2000–2011. AIDS 28: 1049–57.

7. PolifkaJE, FriedmanJM (1999) Clinical teratology: identifying teratogenic risks in humans. Clin Genet 56: 409–420.

8. Antiretroviral Pregnancy Registry Steering Committee (2013). Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry international interim report for 1 Jan 1989–31 July 2013. Wilmington (North Carolina): Registry Coordinating Center. Available: http://www.APRegistry.com.

9. GomezO, MartinezJM, OlivellaA, BennasarM, CrispiF, et al. (2014) Isolated ventricular septal defects in the era of advanced fetal echocardiography: risk of chromosomal anomalies and spontaneous closure rate from diagnosis to age of 1 year. Ultrasound Obstet Gynecol 43: 65–71.

10. BroglySB, AbzugMJ, WattsDH, CunninghamCK, WilliamsPL, et al. (2010) Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trial protocols 219 and 219C. Pediatr Infect Dis J 29: 721–727.

11. WattsDH, HuangS, CulnaneM, KaiserKA, ScheuerleA, et al. (2011) Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. J Perinat Med 39: 163–170.

12. BoydPA, HaeuslerM, BarisicI, LoaneM, GarneE, et al. (2011) Paper 1: The EUROCAT network – organization and processes. Birth Defects Res A Clin Mol Teratol 91 Suppl 1: S2–S15.

13. FordN, CalmyA, MofensonL (2011) Safety of efavirnez in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 25: 2301–2304.

14. MehtaU, ClerkC, AllenE, YoreM, SeveneE, et al. (2012) Protocol for a drugs exposure pregnancy registry implementation in resource limited settings. BMC Pregnancy Childbirth 12: 89.